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Abstract 
A literature review showed that since the discovery of the endogenous 
opioid peptide, Beta-endorphin, and the fact that it is secreted along 
with ACTH as part of the stress response, much investigation has been 
directed toward determination of the role of this substance in auto-
analgesia which is known to result from a variety of stressors. ACTH 
(and presumably, . Beta-endorphin) are known to be secreted in very high 
amounts following stress in 24-hour adrenalectominzed. The present 
study, therefore, predicted that cold water swim (CWS) stress would 
induce analgesia, as measured by the tail-withdrawal analgesia test, 
in .adrenalectomized and control rats, 24 hours and 120 hours after the 
CWS stress occurred. A 3X3X4 analysis of variance with four repeated 
measures indicated that this hypothesis was not supported, although in 
general, stressed animals exhibited significantly longer tail-with-
drawal latencies innnediately after stress than stressed animals receiv-
ing naltrexone and non-stressed animals. It was concluded that further 
investigation is necessary in order to elucidate the physiplogical ba-
sis of autoanalgesia, as well as the biological role of Beta-endorphin 
in response to stress. 
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Introduction 
Much interest and investigation into the area of endogenous opioid 
peptides have been engendered by the biochemical demonstration of the 
existence of opiate receptors by Pert and Snyder (1973). Using tri-
tiated naloxone, an opiate antagonist, morphine binding sites were lo-
calized in the central nervous system and guinea pig intestine. Since 
it would be unlikely that there would be a receptor without there being 
an endogenous ligand, this marked the beginning of the search for an 
endogenous opiate-like substance. 
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Hughes (1975) first isolated a factor from mammalian brain extracts 
which interacted with the opiate receptor and inhibited neurally evoked 
activity in the mouse vas deferens and the guinea pig myenteric plexus. 
Subsequently, Hughes et al (1975) isolated two pentapeptide enkephalins 
from brain with morphinomimetic properties, met-e-:ikephalin and leu-en-
kephalin, and characterized them. 
Beta-endorphin was first identified in the pituitary by Cox et al 
(1975) and was isolated from camel pituitary extracts and characterized 
by Li and Chung (1976). This peptide proved to be identical to sequence 
61-91 (the C-fragment) of the ovine pituitary hormone Beta-lipotropin. 
Two other related peptides, alpha and lambda-endorphins, were also iso-
lated and characterized (Ling and Guillemin, 1976). 
Immunocytofluorescence techniques with well-characterized antisera 
to Beta-endorphin located the peptide in cells of the pars intermedia 
and the pars distalis of the rat hypophysis, but not in the neurohypo-
physis (Bloom et al, 1977). Much smaller amounts of Beta-lipotropin 
and Beta-endorphin have been found in the hypothalamus, substantia nigra, 
thalamus, periacqueductal gray, and the arcuate nucleus of the median 
-eminence (Watson et al, 1977). 
Beta-lipotropin is believed to be the prohormone precursor from 
which Beta-endorphin and the other endogenous opiates are cleaved, 
since Beta-lipotropin itself possesses no opioid activity but does gen-
erate fragments with morphinomimetic activity when incubated (Lazarus 
et al, 1976). Evidnece to support this belief was the finding that o-
vine pituitary contains an enzyme that cleaves the bond between amino 
acids 60-61 of Beta-lipotropin (Bradbury et al, 1976). 
The presence of endorphins within fiber tracts of the central 
nervous system known to be associated with the transmission of pain 
impulses led to the speculation that Beta-endorphin might act as an en-
dogenous opioid to modulate the perception of pain. Receptor binding 
assays indicate that Beta-endorphin is more potent than the exogenous 
opiates (Li and Chung, 1976; Bradbury et al, 1976) and the enkephalins 
(Bradbury et al, 1976) in displacing tritiated opiate agonists and an-
tagonists from the receptor, thereby indicating a high affinity of this 
endorphin for the opiate receptor. 
Beta-endorphin has been shown to possess analgesic properties when 
administered through several routes to several species. Dose-dependent 
elevation of response latencies in tail-flick and hot plate procedures 
was produced when it was administered to mice intracerebrally and in-
travenously (Tseng et al, 1976), and to rats when administered intra-
ventricularly (Bloom et al,- 1976). These effects, with the exception 
of intravenous injection, were shown to be 18 to 33 times more potent 
than the effects of morphine, and were immediately reversed by the ad-
ministration of naloxone (Loh et al, 1976). Dependency to Beta-endor-
phin and cross-tolerance with morphine have also been demonstrated 
2 
(Tseng et al, 1977). 
Since the early studies of Selye in the 1950's it has been recog-
nized that adrenocorticotrophic hormone (ACTH) is the primary pituitary 
hormone secreted in response to acute stress. ACTH is also thought to 
be originally formed as part of the Beta-lipotropin molecule since it 
is identical to sequence 1-39 of Beta-lipotropin. More recently it 
3 
has been demonstrated that the endogenous opiate-like peptide, Beta-en-
dorphin, is also secreted as part of the · stress response (Guillemin et 
al, 1977). It was demonstrated that plasma and pituitary concentrations 
of both ACTH and Beta-endorphin were found to vary concomitantly in-all 
situations investigated, including response to traumatic stress, re:-,o 
sponse to purified corticotropin- .·releasing factor in vitro, and in re-
sponse to adrenalectomy. In addition, ACTH and Beta-endorphin secre-
tion is inhibited by pretreatment with dexamethasone, a synthetic 
glucocorticoid (French et al, 1977). Guillemin et al (1977) hypothesize 
that a holistic response of the organism to stress involves the secre-
tion of pituitary hormones, some (such as ACTH and growth hormone) of 
which are involved in somatotropic · (metabolic) adaptive reactions, 
whereas others (such as Beta-endorphin) are involved in neurotropic or 
psychotropic adaptive reactions. 
As a result of these findings, there has been a vast amount of re-
search attempting to relate Beta-endorphin to. the occurrence of non-
pharmacologically-induced analgesia (autoanalgesia), which has been 
demonstrated in man and other species after exposure to a wide variety 
of natural and experimentally-induced stressful situations. Beecher 
(1957) first noted that soldiers injured on the battlefield rarely com-
plained of pain from even the most serious woundsw Conditioned fear 
(Chance et al, 1978), inescapable footshock (FS) (Akil et al, 1976), 
hypertension-induction (Zamir and Segal, 1979), centrifugal rotation 
(Hayes et al, 1978), 2 deoxy-D-glucose (2-D::-G) injections (Spiaggia 
et al, 1979), and cold water swim (CWS) (Lal, Spaulding and Fielding, 
1978) have all been shown to produce analgesia in rats. In addition, 
it has been shown that FS stress in rats promotes a five to sixfold 
increase in both Beta-endorphin and ACTH plasma levels (Rossier et al, 
1977). 
Although much evidence seems to suggest that autoanalgesia is me-
diated through the activation of central endorphin systems, there is 
also evidence to suggest that endorphins do not mediate stress-induced 
analgesia. Naloxone, which antagonizes endorphin analgesia (Tseng et 
al, 1976) only partially reverses footshock (Akil et al, 1976) and CWS 
(Lal, Spaulding and Fielding, 1978) analgesias. Normal animals pre-
treated with corticosterone were found to exhibit analgesia after CWS, 
an unexpected result if the stress were mediated by Beta-endorphin 
I 
(Bodnar et al, 1979). In addition, it was shown that exposure to brief 
ether anesthesia or horizontal oscillation, both of which have been 
reported to increase ACTH secretion, did not produce analgesia in rats 
as measured by the tail-flick test (Hayes et al, 1978). Therefore, the 
mechanism(s) underlying autoanalgesia remain undetermined, thereby ne-
cessitating further research. 
Ruhmann-Wennhold and Nelson (1977) demonstrated that, in adrenal-
ectomized rats, ACTH secretion reaches a peak about two hours after 
surgery and drops down to normal levels within 24 hours as the animal 
presumably recovers from stress. Since there is no corticosteroid 
feedback present, however, there is then a slow, steady rise in 
4 
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AGTH secretion, even in the absence of additional stress. In rats that 
were stressed 24 hours after surgery, ACTH secretion was greatly increas-
ed, and by one week later reached levels approximately four times grea-
ter than in non-stressed adrenalectomized rats. 
Since high ACTH levels had been shown to be accompanied by high 
Beta-endorphin levels (Guillemin et al, 1977), Holaday et al (1979) 
tested for analgesia in adrenalectomized animals. They found that 
adrenalectomy alone, i.e. in non-stressed animals, did not produce anal-
gesia as measured by the tail-flick test, since no differences between 
latencies were observed in adrenalectomed animals and sham-adrenalecto-
mized controls, one week after surgery. They concluded that either the 
apparent adrenalectomy-induced increases in circulating endorphin 
concentrations do not change analgesic thresholds, or that a functional 
tolerance may have occurred. However, since they did not stress their 
animals as did Ruhmann-Wennhold and Nelson (1977), perhaps Beta-en-
dorphin levels did not reach levels high enough to induce analgesia. 
The present study, therefore, proposed to investigate the effect 
of adrenalectomy combined with a well-established analgesia-inducing 
stressor, CWS, on analgesia in rats. Adrenalectomized, sham-adre-
nalectomized and control rats were subjected to one of three experimen-
tal treatments: Stress (CWS), stress and naltrexone ► or non-stress, 
in a 3X3X4 factorial design with four repeated measures over a period 
of seven days after surgical treatment. 
Four analgesia tests were administered to each animal: A pre-
test to establish a baseline measurement of tail-withdrawal latencies 
before the stress treatment, a second test (post-test~!) immediately 
after the CWS, a third test (post-test II) 24 hours after the CWS, and 
a fourth test (post-test III) 120 hours after the post-test II. 
Since Ruhmann- Wennhold and Nelson (1977) demonstrated that be-
tween two and 24 hours following adrenalectomy, ACTH secretion was in 
the normal range, in correspondence to the recovery of the animal from 
the stress of adrenalectomy, it was hypothesized that 24-hour adrenal-
ectomized animals before exposure to CWS stress (pre-test) would exhi-
bit the same tail-withdrawal latencies as sham-adrenalectomized and 
control rats. 
It has also been demonstrated that the immediate ACTH response of 
24-hour adrenalectomized animals to stress was very similar to the re- · 
spouse of intact animals. Mean plasma ACTH stress responses of 5.6 mU/ 
100 ml. and 6.1 mU/100 ml. were demonstrated for intact and 24-hour a-
drenalectomized animals respectively (Ruhmann-Wennhold and Nelson, 
1977). Therefore, it was hypothesized that adrenalectomized-stressed 
rats, immediately after exposure to CWS stress (post-test I) would 
exhibit the same tail-withdrawal latencies as sham-adrenalectomized-
stressed rats and control-stressed rats. 
6 
Ruhmann-Wennhold and Nelson (1977) also showed that ACTH secretion 
following stress was maintained for one hour in intact animals, but con-
tinued to increase in adrenalectomized animals. By seven days plasma 
ACTH levels increased to 57 mU/100 ml., an increase of approximately 
ten times the normal level. Therefore, it was hypothesized that adre-
nalectomized-stressed rats would not exhibit the same tail-withdrawal 
latencies as sham-adrenalectomized and control-stressed rats, 24 hours 
and 120 hours after exposure to CWS stress. It was predicted that 
adrenalectomized-stressed rats would exhibit significantly longer la-
tencies than sham-adrenalecomized-stressed rats and control-stressed 
rats on post-tests II and III. 
It was also predicted that all stressed animals (not receiving .: 
naltrexone) would exhibit significantly longer tail-withdrawal laten-
cies than non-stressed controls at the post-test I. In addition, it 
was predicted that all stressed animals (not receiving naltrexone) 
would exhibit longer tail-withdrawal latencies at post-test I than at 
the pre-test. Finally, it was predicted that stressed animals that re-
ceived naltrexone would exhibit shorter tail-withdrawal latencies than 
stressed animals that did not receive naltrexone. 
Method 
Subjects 
7 
Ninety Sprague-Dawley male albino rats obtained from the Charles 
River Breeding Laboratories served as subjects. Animals weighed approx-
imately 225 to 325 grams and were housed individually in a temperature 
and humidity-controlled room with a normal diurnal (12 hour light/12 
hour dark) lighting cycle. Food and tap water were available to all 
animals ad• libitum, and .4 molar saline was available to the adrenalec-
tomized animals. 
Apparatus 
The apparatus for the CWS was a 95 cm. high cylindrical pail, with 
a diameter of 31 cm., filled to a height of 18 cm. with water and 
0 
crushed ice in order to maintain a water temperature of 2-4 C. Stan~ 
dard rat restrainers were used to restrain rats during analgesia test-
ing. 
Procedure 
Animals were randomly assigned to one of nine groups as follows: 
1) adrenalectomy + stress, 2) adrenalectomy +stress+ naltrexone, 3) 
adrenalectomy + nonstress, 4) sham-adrenalectomy + stress, 5) sham-
adrenalectomy +stress+ naltrexone, 6) sham-adrenalectomy + nonstress, 
7) control+ stress, 8) control+ stress+ naltrexone, and 9) control 
+ nonstress (see Figure 1). Therefore, there were three surgical 
treatments (adrenalectomy, sham-adrenalectomy, and control) and three 
stress treatments (stress, stress+ naltrexone, and non-stress). 
On each day, surgery was performed between 12 p.m. and 6 p.m. 
Adrenalectomies were performed by bilateral dorsal incisions under pen-
tobarbital (10 mg./kg. body weight, IP) anesthesia. At the time .of 
surgery, adrenal glands were inspected in order to insure that they 
were intact. Animals from which non-intact adrenals were removed were 
discarded from the study. The successful completion of surgery was 
also confirmed by the measurement of saline intake for two weeks fol-
lowing surgery. Sham-adrenalectomies were performed in the same manner 
except that adrenal glands were exposed but not removed. 
Three adrenalectomies (one from each of the three adrenalectomy 
groups). and three sham-adrenalectomies (one from each of the three 
sham-adienalectomy groups) were performed on any given day. During 
this time, the three corresponding control animals (animals receiving 
no surgical treatment) remained in home cages. This day was designated 
Day 1 for these animals. 
On Day 2, the various stress treatments were administered. The 
stress treatment (CWS) consisted of gently placing an animal into a 
0 pail of iced water (2-4 C) for 3.5 minutes, a precedure which has been 
shown to reliably induce analgesia (Bodnar , et al, 1979). Animals in 
the nonstress groups remained in restrainers during this time. 
Animals in the stress+ naltrexone groups received naltrexone 
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(10 mg./kg. body weight, IP) in a solution of 10 mg. naltrexone per 1 
ml. distilled. Injections were given 20 minutes before the animal's 
first analgesia test (pre-test), and again every 24 hours thereafter 
for the remainder of the testing period, to insure continuous block-
ade of opiate receptors after the initial 24 hour surgery recovery per-
iod. Tests on these groups enabled the assessment of analgesia without 
the presence of Beta-endorphin activity. 
Analgesia was tested by the tail-withdrawal method as described 
by Miksic and Lal (1977). Animals were placed in restrainers with their 
Q 
tails hanging freely. Tails were then immersed 5 cm. in 55 C water, 
in order to induce a pain response (tail-withdrawal). Latency to 
tail-withdrawal for each animal was recorded by an electronic timer to 
the nearest .01 second. During the analgesia testing the experimenter 
was blind as to animal group membership. 
Pre-test. On Day 2, approximately 24 hours after surgery, animals 
were placed into restrainers, After ten minutes of habituation each 
animal was tested for analgesia. This measurement was taken in order 
to establish a pre-stress baseline for each animal, and to compare in-
itial latencies among groups. Immediately after the pre-test, animals 
in the stress groups were stressed while .animals in . the .nonstress groµps 
remained .in their restrainers. 
Post-test I. After CWS, each anilna,l was returned to its restrainer. 
After a ten minute habituation period, all animals were tested for an-
algesia. This measurement was used to assess analgesia resulting from 
the stress treatment, and to compare latencies among all groups. Each 
animal was then returned to its home cage. 
Post-test II. On Day 3, approximately 24 hours after the post-
11 
test I, animals were placed into restrainers. After a ten minute 
habituation period each animal was tested for analgesia. This measure-
ment was used to assess differences in the time-course of analgesia a-
mong groups. Each animal was then returned to its home cage. 
Post-test III. On Day 8, approximately 120 hours after the post-
test II, animals were placed into restrainers . After a ten minute ha-
bituation period, each animal was again tested for analgesia. This 
measurement was used to further assess differences in the time-course 
of analgesia among groups. Each ·animal was then returned to its 
home cage. 
Results 
Means and standard deviations for all nine experimental groups across 
four repeated measures are presented in Table 1. The data of one ani-
mal from the adrenalectomy + stress group was discarded since the ani-
mal died before the completion of the experiment. Examination of the 
data suggested that cell variances were heterogeneous. An F test 
max 
indicated that violation of the assumption of homogeneity of variance 
was present, .F (36,9) = 47 .84, .2.< .01. A log (X + 1) transforma-
max 
tion was executed and was successful in removing the heterogeneity of 
variance, Fmax (36,9) = 8.02, Ji>.05. Means and standard deviations for 
the transformed data are presented in Table 2. 
A 3X3X4 analysis of variance with four repeated measures was per-
formed on these transformed data using the BMD P2V statistical package. 
An analysis of variance summary table is presented in Table 3. The 
analysis indicated that the surgical treatment produced no significant 
differences among groups, !. (2, 71) = 1.93, .E. )' .05. The stress treat-
ment, however, did produce a significant difference among groups,!. 
TABLE 1 
Means and Standard Deviations of Latencya to Tail-
Withdrawal for Each Experimental Group Across Four 
Repeated Measures 
Treatment Pre-test Post-test I Post-test II Post-test 
Group n M SD M SD M SD M SD 
AX+S 8 3.50 2.16 7.39 2.72 3.63 2.19 2.60 .33 
AX+S+N 9 3.27 1.92 5.26 1.82 3.02 1.45 3.73 .61 
AX+NS 9 2.81 .48 4.54 .90 3.32 .78 2.86 .50 
SH+S 9 2.50 .55 7.70 3.32 3.46 • 70 3.57 .42 
SH+S+N 9 3.16 1.16 6.54 2.09 3.41 1.28 3.47 .32 
SH+NS 9 2.81 1.22 4.37 1.40 2.78 1.30 2.78 .28 
c+s 9 2.64 .97 5.87 1.24 3.56 1.57 3.10 .36 
S+S+N 9 2.36 .86 5.54 1.04 ' 2.72 • 77 3.23 .56 
C+NS 9 2.04 • 71 3.55 1.89 2.90 .81 2.94 .46 
a = latency in seconds 
n = number of subjects per cell 
AX = adr enalec tomy 
SH= sham-adrenalectomy 
C -= control 
s = stress 
N = naltrexone 
NS= nonstress 
12 
III 
TABLE 2 
Means and Standard Deviations 
of Transformed Data 
Treatment Pre-test Post-test I Post-test II 
Group M SD 
AX+S .63260 .16• 
AX+S+N .60012 .16 
AX+NS .• 57806 .06 
SH+S .53900 • 07 
SH+S+N .60409 .12 
SH+NS .56287 .13 
c+s .54614 .13 
C+S+N .51304 .12 
C+NS .47354 .09 
AX= adrenalectomy 
SH= sham-adrenalectomy 
C = control 
S = stress 
N = naltrexone 
NS= nonstress 
M SD M SD 
.90474 .14 .62574 .20 
• 78028 .13 .57999 .15 
.73812 .07 .61782 .09 
.90908 .18 .64438 .07 
.86333 .12 .62875 .13 
• 71336 .14 .55384 .15 
.83034 • 08 • 63466 .15 
.80948 :08 .56203 .09 
.62599 ~17 .58250 . 09 
13 
Post-test III 
M SD 
.54968 .11 
.64705 .17 
.55249 .19 
.64341 .13 
.64188 .09 
.56793 .09 
.59936 .11 
.60550 .13 
.56917 .16 
Source 
TABLE 3 
Summary Table for 3X3X4 Analysis of 
Variance with Fcur Repeated Measures 
of variation ss df MS 
A (Surgery treatment) .11994 2 .05997 
B (Stress 
AB 
Error 
C (Trials 
AC 
BC 
ABC 
Error 
* p<'.. .01 
** p <.. 001 
treatment) .33022 
.03622 
2.21155 
) 2. 73231 
.08878 
.27971 
·.12289 
2.48108 
2 .16511 
4 .00906 
71 • 03115 
3 .91077 
6 .01480 
6 .04662 
12 .01024 
213 .01165 
14 
F 
1.93 
5.30* 
.29 
78 .19** 
1. 27 
4.00** 
. 88 
(2,71) = 5.30, .E. .01. An Eta squared indicated that this significant 
treatment effect accounted for approxi~tely 4% of the total variance 
(If/..~= .0393). Results also indicated that no significant surgery X 
stress interaction was found, F (4,71) = .29, .E_>.05. 
15 
For the repeated measures within subjects it was found that a sig-
nificant difference among trials occurred, ! (3,213 = 78.19, .E. <'.'...001. 
An Eta squared indicated that this factor accounted for approximately 
z 32.5% of the total variance (1[ = .3252). The stress X repeated mea-
sures interaction was also found to be significant, F (6,213) = 4,00, 
.E.<.00l, while the surgery X repeated measures and the surgery X stress 
X repeated measures interactions were not, F (6,213) = 1.27, .E. ?.05, 
and!. (12,213) = .88, .E.)' .05 respectively. An Eta squared indicated 
that approximately 3% of the total variance was accounted for by the 
significant stress X repeated measures inter.?ction ('n~ .0333). 
To further investigate the significant stress X repeated measures 
interaction, simple effects tests were performed. Variation due to the 
simple effects was computed from the stress X repeated measures summary 
table which is presented in Table 4. 
The profiles of means corresponding to the cell totals of the sum-
mary table are plotted in Figure 2. The profiles indicate that all 
three stress groups showed an increase in latency to tail-withdrawal 
at post-test I, which occurred immediately after the CWS stress for the 
stress and the stress+ naltrexone groups. It is interesting to note 
that the non-stress group also showed an increase in tail-withdrawal 
latency at this point in time. At post-tests II and III the tail-with-
drawal latencies for all three groups generally decreased. 
An analysis of variance for the simple effects of the stress 
s 
S+N 
NS 
TOTALS 
16 
TABLE 4 
Stress X Repeated Measures Summary Tablea 
Pre-test Post-test I Post-test II Post-test III Totals 
15.159 23.471 16.908 15.911 71.4996 
15.243 21. 775 . 15.719 16.816 69.5536 
14.331 18 .441 15.660 14.998 63.4303 
44.7336 63.6878 48.2868 47.7253 204.4335 
a= numbers in table represent totals for each stress group 
collapsed across surgery groups 
S = stress (e.g. Adrenalectomy + S, Sham~Adrenalectomy + S, 
and Control+ Stress groups combined) 
N = naltrexone 
NS= nonstressed 
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factor indicated that there was a significant difference among the three 
stress groups at post-test I, F (2,57) = 14.88, .E.<. 01, but that no 
significant differences among the groups occurred at pre-test 1 F (2,57) 
= .58, .£_) .05, or post-tests II and III, F (2,57) = 1.13, .E_">.05, and 
F (2,57) = 1.88, .£_) .05, respectively. An analysis of variance sum-
mary table is presented in Table 5. 
To further investigate the significant difference among stress 
groups that occurred at post-test I, a Newman-Keuls analysis was per-' 
formed. It was found that all three groups were significantly different 
from each other. Figure 2 shows that the stress group exhibited sig-
nificantly longer tail-withdrawal latencies than the stress+ naltrexone 
group <..E.< 01) and _the non-stress group (.£. ~.01), and the stress + nal-
trexone group exhibited significantly longer tail-withdrawal latencies 
than the non-stress group (.£. <. 05). A summary of the Newman-Keuls 
test is presented in Table 6. 
An analysis of variance for the simple effects of the repeated 
measures factor indicated that there were significant differences among 
the four trials for the stress group,!_ (3,213) = 46.73, .£_<.01, for 
the stress + naltrexone group, . F (3,213) = 28. 97, .E. <.. 01, and the non-
stress group,!_ (3,213) = 10.51, .E_<.01). An analysis of variance sum-
mary table is presented in Table 7. Three additional Newman-Keuls an-
alyses were performed to investigate these significant differences. 
Summaries of these Newman-Keuls tests are presented in Tables 8, 9, and 
10. 
The Newman-Keuls analysis of the differences among the four trials 
for the stress group indicated that post-test I tail-withdrawal laten-
cies were significantly longer than tail-withdrawal latencies at all 
Source 
Stress at 
Stress at 
Stress at 
Stress at 
Error 
TABLE 5 
Analysis of Variance Summary Table for 
Simple Effects of Stress 
of variation ss df MS 
pre-test .0191 2 .00955 
post-test I .4919 2 .24595 
post-test II .0373 2 .01865 
post-test III .0621 2 .03105 
. 57 
.01540 
19 
F 
.5779 
14.8835* 
1.1286 
1.8789 
----
TABLE 6 
Newman-Keuls Sunnnary Table for 
Stress at Post-test Ia 
Nonstress Stress + Naltrexone 
.6924 .8177 
Nonstress .6925 
** 
Stress + N .8177 
Stress .8814 
r = 2 
a) numbers in table represent means for each stress group 
for post-test I. 
** p<.01 
* p<.os 
df = (r,71) 
20 
Stress 
.8814 
** 
* 
3 
TABLE 7 
Analysis of Variance Summary Table for 
Simple Effects of Trials 
Source of -variation 
Trials for stress 
Trials for stress+ drug 
Trials for non-stress 
Error 
ss 
1.633 
1.0125 
.3673 
df 
3 
3 
3 
2. 48108 213 
MS 
.5444 
.3375 
.1224 
.01165 
F 
46.7296* 
28.9699* 
10.5064* 
21 
TABLE 8 
Newman-Keuls Summary Table for 
Trials at Stress Groupa 
Pre-test Post-test III Post-test II Post-test . 
• 56924 .59748 .63493 
Pre .56924 
------ n. s. ** 
III .59748 
------ * 
II .63493 
------
I .88139 
r = 2 3 
a) numbers in table represent means for each trial for the 
stress group 
** p <. 01 
* p<.05 
n .s. = not significant 
df = (r, 213) 
.88139 
** 
** 
** 
-----
4 
22 
I 
Pre .57241 
II .59026 
III .63148 
I .81770 
r = 
TABLE 9 
Newman-Keuls Summary Table for 
Trials at Stress+ Naltrexone Groupa 
Pre-test Post-test II Post-test 
• 57 241 .59026 .63148 
------ n.s. ** 
------ * 
------
2 3 
III Post-test 
.81770 
** 
** 
**··. 
-----
4 
a) numbers in table represent means for each trial for the 
stress+ naltrexone group 
** pc(.. 01 
* p <. 05 
n.s. = not significant 
df = (r,213) 
23 
I 
TABLE 10 
Newman-Keuls Summary Table for 
Trials at Nonstressa 
Pre-test Post-test III Post-test II Post-test 
.53816 .56320 .58806 
Pre .53816 ------ n. s. * 
III .56320 --·~-- . n.s • 
II • 58806 
------
I .69249 
r = 2 3 
a) numbers in table represent means for each trial for the 
non-stress group 
n.s. = not significant 
df = (r, 213) 
.69249 
** 
** 
** 
-----
4 
24 
I 
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other tests.(E_<..Ol). The post-test II latencies were significantly 
longer than the pre-test (.E_<.01) and post-test III latencies (.E_<..05). 
The Newman-Keuls analysis of the differences among the four trials 
for the stress+ naltrexone groups indicated that post-test I latencies 
were significantly longer than latencies at all other tests (.E.<-.ol), 
and that the post-test III latencies were significantly longer than the 
pre-test (.E_<.01) and post-test II (.E_<.05) latencies. 
The Newman-Keuls analysis of the differences among the four trials for 
the non-stress groups indicated that post-test I latencies were signi-
ficantly longer than latencies at all other tests (£.<.01), and that 
the post-test II latencies were significantly higher than the pre-test 
latencies (.£.<. 05). 
On the basis of the above analyses it was concluded that the sig-
nificant stress X repeated measures interaction can be accounted for 
by _the occurrence of significant differences in latencies among the 
three stress groups at the post-test -I only and sifnificant differences 
in latencies within each stress group over time, 
Although the overall F test for the main effect of surgery was 
found to be non-significant, specific individual comparisons among 
certain group means were made on the basis of a priori predicted out-
comes. 
One such comparison was performed to investigate whether a signif-
icant difference occurred at the pre-test, between the adrenalectomy + 
stress group, and the sham-adrenalectomy + stress and control+ st~ess 
groups combined. It was found that no significant difference occurred, 
F (1, 71) = 1.22, _p_) .05. 
A second comparison was performed to investigate whether a signif-
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icant difference occurred at the post-test I, between the adrenalectomy 
+ stress group, and the sham.-adrenalectomy + stress and control+ stress 
groups combined. It was found that no significant difference occurred, 
F ( 1, 71) = • 23 , .E. > • 05 • 
A third comparison was performed to investigate whether a signif-
icant difference occurred at the post-test II, between the adrenalectomy 
+ stress group, and the sham-adrenalectomy + stress and control+ stress 
groups combined. It was found that no significant difference occurred, 
F (1, 71) = .04, .£.>.05. 
A final comparison was performed to investigate whether a signif-
icant difference occurred at the post-test III, between the adrenalec-
tomy + stress group and the sham-adrenalectomy + stress and control+ 
stress groups combined. It was found that no signifcant difference 
occurred, F (1,71) = .98, p>.os. 
Discussion 
In summary, the results indicated that no significant dif-
ference occurred among the three surgical treatment groups, contrary 
to expectation. However, as predicted _, it was found that CWS stress 
induced significantly longer tail-withdrawal latencies in all stressed 
animals. 
As indicated by the lack of significance of the main effect for 
surgery, no significnat difference was found among the three surgical 
treatment groups. An additional analysis by an individual comparison 
of means indicated that the adrenalectomy + stress group exhibited the 
same pre-test latencies as the sham-adrenalectomy + stress and the con-
trol+ stress groups, as hypothesized. Another individual comparison 
of means found no significant difference in post-test I latencies be-
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tween the adrenalectomy + stress group and the sham-adrenalectomy + 
stress and control+ stress groups, also as hypothesized, Two addition-
al individual comparisons of means indicated that, contrary to the hy-
pothesis, no significant difference in post-test II or post-test III 
latencies occurred between the adrenalectomy + stress group, and the 
sham-adrenalectomy + stress and control+ stress groups. 
Essentially, adrenalectomized animals exhibited the same tail-
withdrawal latencies as sham-adrenalectomized animals and non-operated 
controls across all four trials, Three explanations of these results 
are possible, First, Beta-endorphin may not be secreted concomitantly 
with ACTH over such a long period of time. This is doubtful in light 
of the remarkable parallelism exhibited between the two peptides in all 
other experimental situations, but could easily be investigated _ by the 
collectinn and analysis of blood samples by means of permanent catheter 
implantations at the time of surgery. Second, tolerance - to Beta-endor-
phin may have developed over the time course of the experiment, This 
could be investigated by administration of 'naltrexone to animals, as in 
this study; : and then withdrawing the drug and testing for analgesia. 
Presumably, naltrexone administration would block opiate receptors and 
prevent the occurrence of tolerance, Third, Beta-endorphin may be se-
creted in increasing amounts following stress _ in adrenalectomized an-
imals, but may not be the substance/mechanism responsible for the anal-
gesia observed after CWS stress. Clearly, further research . is neces-
sary to make any conclusions regarding these results. 
As ,;•as expected, it was found that all stressed animals that did 
not receive naltrexone, regardless of surgical treatment, exhibited " 
significantly longer tail-withdrawal latencies than the non-stressed 
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controls at post-test I. It was concluded therefore~ that CWS stress 
did induce significant analgesia in these animals. Similarly, all 
stressed animals that did not receive naltrexone exhibited significant-
ly longer tail-withdrawal latencies after stress (at post-test I) than 
before stress (at pre-test), as predicted. These findings are well- -
documented with CWS as the stressor (Lal, Spaulding, and Fielding, 
1978; Bodnar et al, 1979). 
In contrast to the findings of other researchers (Lal, Spaulding, 
and Fielding, 1978) it was found that non~stressed animals also exhibi-
ted significantly longer latencies at the post-test I than on the pre-
test. An important difference in the design of the present experiment 
seems to account for this finding. Non-stressed animals in the present 
study were restrained for ten minutes, were tested for analgesia (pre-
test), and remained in restrainers for the 3.5 minute stress period and 
for an additional 10 minutes before the post-test I. Non-stressed 
animals in the previous study remained in restrainers for five minutes, 
were tested for analgesia, and then were tested again five minutes 
later. Perhaps restraint and/or immersion of the tail in hot water in-
duced the significantly longer latencies for the non-stress group. It 
is possible that this showed up in the present experiment since animals 
were retested 13.5 minutes later, while in the previous study they 
were tested only five minutes later. _ 
The prediction that animals · in the stress+ naltrexone group would 
exhibit shorter tail-withdrawal latencies than stressed animals that 
did not receive naltrexone was not supported since the naltrexone group 
exhibited significantly shorter latencies only at the post-test I. No 
significant differences occurred at either post-tests II or III. In 
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addition, the naltrexone group displayed significantly longer latencies 
than the non-stress group at post-test I, an unexpected finding if Beta-
endorphin is to be implicated in stress-induced analgesia, since revers-
ibility of effects by naloxone is a universally accepted test of opioid 
peptide activity (Grevert and Goldstein, 1977). 
Although quite unexpected, this finding is well-documented in the 
literature. In fact, this is a very controversial point in that some 
studies report that naloxone partially reverses stress-induced auto-
analgesia, while others report no reversal at all. The matter is fur-
ther complicated by the fact that some researchers call partial re-
versal, what others call lack of antagonism. 
Lal, Spaulding, and Fielding (1978) concluded that analgesia in-
duced by CWS stress was not antagonized by naloxone in either rats nor 
mice as measured by tail-withdrawal, tail-flick and phynylquinone-wri-
thing analgesia tests. Their data appear to reflect what others (Akil 
et al, 1976) call partial reversal, since latencies of groups receiv-
ing naloxone fell between the stress groups and the control groups. 
Akil et al (1976) reported partial reversal by naloxone of analgesia 
induced by acute footshock (FS) stress. Chance and Rosecrans (1979) 
found that large doses of naloxone failed to "modify" analgesia elicited 
by acute FS or conditioned fear in rats. They also found that nal-
oxone failed to "modify"analgesia following FS in mice. Their data 
appear to reflect the occurrence of.complete failure to reverse analge-
sia since the latencies of naloxone-treated animals were equal to the 
latencies of stressed animals. Similarly, El-Sobky, Dostrovsky, and 
Wall (1976) reported that the perception of pain induced by electric 
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shock to _ the forearm, in quman subjects, was not altered by administra-
tion of naloxone. These researchers found no significant differences 
in analgesia between groups receiving naloxone and controls. 
Contrary to the findings that report naloxone's partial reversal 
or non-reversal of autoanalgesia, Lewis, Cannon, and Liebeskind (1980) 
demonstrated that inescapable FS in rats caused profound analgesia that 
was completely antagonized by naloxone when shock was delivered inter-
mittently for 30 minutes. In contrast, when shock was delivered con~ 
tinuously for three minutes, it was found that naloxone failed to an-
tagonize the analgesic response to the stressor. 
Additional evidence for the involvement of Beta-endorphin in al~ 
terations of pain threshold is accumulating. Dehen et al (1977) stu~ 
died the effect of naloxone on one patient with congenital insensitiv-
ity to pain. No significant variation in pain threshold was observed 
in normal controls after naloxone or placebo. For the patient, the pain 
threshold fell by 67% within _ten minutes of naloxone injection, while 
no significant effect was observed with a placebo. It was postulated 
that congenital insensitivity to pain may be related to a tonic hyper-
activity of an endogenous opioid peptide system. 
Hosobuchi et al (1979) found that stimulation of the periac-
queductal gray area produced significant analgesia in human patients 
with chronic pain of peripheral origin,' In addition, this stimulation 
resulted in significant increases (50-300%) in the concentration of 
ventricular i.mmunoreactive Beta-endorphin, and its effects were reversed 
by naloxone. 
In sum, evidence both for and against the role of Beta-endorphin 
in non-pharmacologically induced analgesia continues to accumulate. 
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Many different explanations have been offered in the attempt to resolve 
the issue. 
One such proposal is that perhaps another endorphin that is not 
antagonized by naloxone mediates stress-induced analgesia, since the 
occurrence of a naloxone-insensitive endorphin in the CNS is not unpre-
cedented (Lal, Spaulding, and Fielding, 1978). 
Lewis, Cannon and Liebeskind (1980) proposed that there are two 
substrates involved in stress-induced analgesia. As described above, 
FS stress, depending only on its temporal characteristics, -appears to 
activate either an opioid or non-opioid analgesia mechanism, each with 
physiologic inputs that are activated by certain stress conditions. 
Similarly, Spiaggia et al (1979) propose the existence of at least 
two independent pain-inhibitory branches of a pain-modulatory system, 
one with opiate-like characteristics which is activated by acute expos ure 
to morphine, and one 'with non-opiate characteristics, which is activa-
ted by acute exposure to such stressors as CWS. They demonstrated that 
full and reciprocal cross-tolerance develops to the analgesic effects 
of two qualitatively different stressors, CWS and 2-deoxy-D-glucose 
(2~D-G) injections, but that these two stressors differed in .their re-
spective interactions with opiate analgesia. Analgesia induced by CWS 
and that induced by morphine were found to be independent of each other 
since cross-tolerance failed to develop between them. Animals made 
tolerant to morphine, however, failed to exhibit 2-D-G analgesia, in-
dicating that cross-tolerance between these two agents did occur. 
In addition, Hayes et al (1978) demonstrated that bilateral lesions 
of the dorsolateral funiculus of the rat spinal cord reduced morphine 
analgesia by 73% but haa no effect on shock-produced analgesia in the 
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' 
same rats. These results suggested that narcotic and non-narcotic mod-
ulation of nociceptive input at the spinal level involves supraspinal 
mechanisms descending via separate pathways in the spinal cord, 
Thus, it appears that the results of the present study and those 
reported by others, may be possibly explained by an as yet undetermined 
non-opiate mechanism. It is known that a myriad of responses are evoked 
in an organism in response to stress; any one of these may be implicated 
in the mediation of autoanalgesia. Clearly, further investigations 
utilizing neurochemical, neurophysiologica~ and behavioral assessments 
are necessary in order to fully elucidate the physiological basis of 
stress-induced analgesia, as well as the biological role of Beta-endor-
phin in response to stressful situations. 
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